Heffernan Michael Thomas bought ENGN
July 8, 2025 · Form 4 insider transaction
Heffernan Michael Thomas bought 45,000 shares of enGene Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
45,000
Price
$0.00
Total value
N/A
InsiderHeffernan Michael Thomas
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJuly 8, 2025
Filing dateJuly 10, 2025
Shares owned after45,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option vests at 1/3 on each of the first, second and third anniversaries of Mr. Heffernan's date of appointment to the Board, which was July 8, 2025.